Clinical Trial Detail

NCT ID NCT04019327
Title A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

prostate adenocarcinoma

Therapies

Talazoparib + Temozolomide

Age Groups: adult senior

Additional content available in CKB BOOST